RMgmDB - Rodent Malaria genetically modified Parasites

Back to search results

Summary

RMgm-4063
Malaria parasiteP. berghei
Genotype
TaggedGene model (rodent): PBANKA_1303400; Gene model (P.falciparum): PF3D7_1439500; Gene product: oocyst rupture protein 2, putative (ORP2; NFYC)
Name tag: mCherry
Phenotype Oocyst; Sporozoite;
Last modified: 24 December 2016, 18:19
  *RMgm-4063
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene tagging
Reference (PubMed-PMID number) Reference 1 (PMID number) : 27982038
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone 8417HP
Other information parent line
The mutant parasite was generated by
Name PI/ResearcherCurrà C, Siden-Kiamos I
Name Group/DepartmentFoundation for Research and Technology-Hellas
Name InstituteInstitute of Molecular Biology and Biotechnology
CityHeraklion
CountryGreece
Name of the mutant parasite
RMgm numberRMgm-4063
Principal nameORP2::mCherry
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageNot different from wild type
Gametocyte/GameteNot different from wild type
Fertilization and ookineteNot different from wild type
OocystIn oocysts ORP2::mCherry was readily detected in the cytoplasm in oocysts at day 7. Cytoplasmic localization was maintained in oocysts until day 12 and before sporozoite formation. When sporozoites had formed and were ready to egress from the oocyst, ORP2 was relocalized to the oocyst periphery where it partly co-localized with Cap380 (PBANKA_1218100), a protein of the oocyst capsule.
SporozoiteIn oocysts ORP2::mCherry was readily detected in the cytoplasm in oocysts at day 7. Cytoplasmic localization was maintained in oocysts until day 12 and before sporozoite formation. When sporozoites had formed and were ready to egress from the oocyst, ORP2 was relocalized to the oocyst periphery where it partly co-localized with Cap380 (PBANKA_1218100), a protein of the oocyst capsule. No mCherry signal was detected in sporozoites after examining the cells in immunofluorescence assays (IFA)
Liver stageNot tested
Additional remarks phenotype

Mutant/mutation
The mutant expresses of C-terminal mCherry-tagged version of ORP2.

Protein (function)
In the paper it is shown that each of two HFD (histone-fold domain)-containing proteins of P. berghei gene (IDs PBANKA_0902500 and PBANKA_1303400), which are named oocyst rupture protein 1 (ORP1) and ORP2, have essential and similar functions in the rupture of the oocyst capsule. Evidence is presented that protein interaction via the HFD is critical for function. ORP1 is located in the oocyst capsule, whereas ORP2 is re-localized from the oocyst cytoplasm to the capsule at the time when mature sporozoites have formed.
The histone-fold domain (HFD) is found in histones and in proteins with a role in transcriptional regulation such as the TATA-box-binding protein-associated factor TAFII and in the CCAAT-binding transcription factor subunits NF-YB and NF-YC. The only example of a protein with a HFD acting outside the nucleus is son-of-sevenless, a protein with multiple domains containing two HFDs, which are involved in binding to lipids. The HFD is B70 amino acids in length and forms three helices separated by small linker sequences. In a heterodimer the proteins are organized in head-to-tail orientation, resulting in a compact ‘handshake’ interaction. In the well-studied NF-Y complex, the heterodimer NF-YB and NF-YC interacts with a third subunit, NF-YA. Although the heterodimer binds DNA in a nonspecific manner, the NF-YA subunit confers binding specificity to the CCAAT motif.
ORP1 (PBANKA_0902500, 950 amino acids) contains a carboxyterminal HFD. ORP2 has an amino-terminal HFD, which is most similar to NF-YC of plants and animals, and HAP5 of yeast. Both HFDs comprises the three a-helices characteristic of the HFD and the short aC helix found in NF-YB/NF-YC proteins. Neither of the two proteins contains any other recognizable motifs and outside the HFD there is only a low degree of similarity comparing the two. The two proteins are considerably longer than NF-YB and NF-YC of animals. BLAST searches of the Plasmodium genome failed to reveal any protein with similarity to NF-YA, which suggested that these two proteins may not be part of a classical NF-Y DNA-binding complex.

Phenotype
No mCherry signal was detected in asexual stages, gametocytes, ookinetes or sporozoites after examining the cells in immunofluorescence assays (IFA)
In oocysts ORP2::mCherry was readily detected in the cytoplasm in oocysts at day 7. Cytoplasmic localization was maintained in oocysts until day 12 and before sporozoite formation. When sporozoites had formed and were ready to egress from the oocyst, ORP2 was relocalized to the oocyst periphery where it partly co-localized with Cap380 (PBANKA_1218100), a protein of the oocyst capsule.

Additional information
See RMgm-4060 for a mutant lacking ORP2 (PBANKA_1303400).
See RMgm-4059 for a mutant lacking ORP1 (PBANKA_0902500).
See RMgm-4061 for a mutant with a mutated histone-fold domain (HFD) of ORP1. Phenotype analyses of this mutant indicates that HFD is essential for ORF function
See RMgm-4062  and RMgm-4063 for mutants expresing GFP-tagged ORP1 version and a mCherry-tagged version of ORP2. Analyses of these mutants show  that ORP1 is located in the oocyst capsule, whereas ORP2 is re-localized from the oocyst cytoplasm to the capsule at the time when mature sporozoites have formed.

Other mutants
See above


  Tagged: Mutant parasite with a tagged gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_1303400
Gene Model P. falciparum ortholog PF3D7_1439500
Gene productoocyst rupture protein 2, putative
Gene product: Alternative nameORP2; NFYC
Details of the genetic modification
Name of the tagmCherry
Details of taggingC-terminal
Additional remarks: tagging
Commercial source of tag-antibodies
Type of plasmid/construct(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr/yfcu
Promoter of the selectable markerpbdhfr
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationThe transgenic parasite line expressing ORP2::mCherry was generated by introducing the coding region of mCherry in the endogenours locus by double crossover. To this end, the last 655bp of the orp2 coding region (amplified with primers 130340CODfor and 130340cod2rev) was fused in frame with the gene encoding mCherry in the pBAT vector using the enzymes SacII–SpeI. A 620bp fragment of the 3'-FR of orp2 (amplified with primers 130340tg-3' for and 130340tg-3'rev) was inserted in the SphI–SacI sites. The last step is the insertion of a 751bp homologous region for recombination just after the orp2 3'-FR region amplified by 130340tg-omfor and 130340tg-omrev in the ApaI–AatII sites. Finally, the plasmid was linearized using the AatII–SacII enzymes before transfection.
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6